These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19196927)

  • 1. Depression in schizophrenia: methodological artifact or distinct feature of the illness?
    Chemerinski E; Bowie C; Anderson H; Harvey PD
    J Neuropsychiatry Clin Neurosci; 2008; 20(4):431-40. PubMed ID: 19196927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Yoruba version of the Beck Hopelessness Scale: psychometric characteristics and correlates of hopelessness in a sample of Nigerian psychiatric outpatients.
    Aloba O; Akinsulore A; Mapayi B; Oloniniyi I; Mosaku K; Alimi T; Esan O
    Compr Psychiatry; 2015 Jan; 56():258-71. PubMed ID: 25446724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive and negative symptoms in schizophrenia and their relation to depression, anxiety, hope, self-stigma and personality traits - a cross-sectional study.
    Vrbova K; Prasko J; Holubova M; Slepecky M; Ociskova M
    Neuro Endocrinol Lett; 2018 Mar; 39(1):9-18. PubMed ID: 29604619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature and prevalence of depression in chronic schizophrenic in-patients.
    Barnes TR; Curson DA; Liddle PF; Patel M
    Br J Psychiatry; 1989 Apr; 154():486-91. PubMed ID: 2574068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia.
    Rocca P; Montemagni C; Castagna F; Giugiario M; Scalese M; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):373-9. PubMed ID: 19211031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in schizophrenia: a comparison of three measures.
    Collins AA; Remington G; Coulter K; Birkett K
    Schizophr Res; 1996 May; 20(1-2):205-9. PubMed ID: 8794511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression in schizophrenia: I. Association with neuropsychological deficits.
    Kohler C; Gur RC; Swanson CL; Petty R; Gur RE
    Biol Psychiatry; 1998 Feb; 43(3):165-72. PubMed ID: 9494697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptoms.
    Leifker FR; Bowie CR; Harvey PD
    Schizophr Res; 2009 Nov; 115(1):82-7. PubMed ID: 19775869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective quality of life and suicidal behavior among Taiwanese schizophrenia patients.
    Kao YC; Liu YP; Cheng TH; Chou MK
    Soc Psychiatry Psychiatr Epidemiol; 2012 Apr; 47(4):523-32. PubMed ID: 21390511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rating depression in schizophrenia. A comparison of a self-report and an observer report scale.
    Addington D; Addington J; Maticka-Tyndale E
    J Nerv Ment Dis; 1993 Sep; 181(9):561-5. PubMed ID: 8245924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.
    Tollefson GD; Sanger TM; Lu Y; Thieme ME
    Arch Gen Psychiatry; 1998 Mar; 55(3):250-8. PubMed ID: 9510219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication.
    Lewine RR
    Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression.
    Zisook S; Nyer M; Kasckow J; Golshan S; Lehman D; Montross L
    Schizophr Res; 2006 Sep; 86(1-3):226-33. PubMed ID: 16750346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do neuroleptics cause depression?
    Roy A
    Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Revealed" Depression and drug treatment for schizophrenia.
    Knights A; Hirsch SR
    Arch Gen Psychiatry; 1981 Jul; 38(7):806-11. PubMed ID: 6113822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of instruments to measure depressive symptoms in patients with schizophrenia.
    Lako IM; Bruggeman R; Knegtering H; Wiersma D; Schoevers RA; Slooff CJ; Taxis K
    J Affect Disord; 2012 Sep; 140(1):38-47. PubMed ID: 22099566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of negative and depressive symptoms: Discriminatory relevance of affect and expression.
    Richter J; Hölz L; Hesse K; Wildgruber D; Klingberg S
    Eur Psychiatry; 2019 Jan; 55():23-28. PubMed ID: 30384108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement and Treatment Research toImprove Cognition in Schizophrenia Consensus Cognitive Battery: validation of the Japanese version.
    Kaneda Y; Ohmori T; Okahisa Y; Sumiyoshi T; Pu S; Ueoka Y; Takaki M; Nakagome K; Sora I
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):182-8. PubMed ID: 23581870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.
    Kim JH; Ann JH; Kim MJ
    Compr Psychiatry; 2010; 51(2):165-70. PubMed ID: 20152297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients.
    Evans JD; Heaton RK; Paulsen JS; Palmer BW; Patterson T; Jeste DV
    Biol Psychiatry; 2003 Mar; 53(5):422-30. PubMed ID: 12614995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.